Insulin resistance/hyperinsulinemia and cancer mortality: The Cremona study at the 15th year of follow-up

Gianluca Perseghin, Giliola Calori, Guido Lattuada, Francesca Ragogna, Erika Dugnani, Maria Paola Garancini, Paolo Crosignani, Marco Villa, Emanuele Bosi, Giacomo Ruotolo, Lorenzo Piemonti

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Type 2 diabetes is associated with risk of cancer. Hyperinsulinemia and insulin resistance may be the link with cancer, but whether this is independent of the diabetes status, obesity/visceral obesity and metabolic syndrome is uncertain and the present study wanted to address this issue. Fifteen-year all-cause, CVD and cancer mortality data were obtained through the Regional Health Registry in 2,011 out of 2,074 Caucasian middle-aged individuals of the Cremona Study, a population study on the prevalence of diabetes mellitus in Italy in which anthropometric and metabolic characteristics were collected. During the 15-year observation period, 495 deaths were registered: 221 CVD related and 180 cancer related. Age and sex were independently associated with all-cause, cancer and CVD mortality rates. Age- and sex-adjusted analysis showed that HOMA-IR, cigarette smoking and diabetes were independently associated with all-cause mortality; HOMA-IR, systolic blood pressure and fibrinogen were independently associated with CVD mortality; HOMA-IR and smoking habit were independently associated with cancer mortality. Individuals in the highest quintile of serum insulin had a 62% higher risk of cancer mortality (HR = 1.62 95% CI: 1.19-2.20; P

Original languageEnglish
Pages (from-to)421-428
Number of pages8
JournalActa Diabetologica
Volume49
Issue number6
DOIs
Publication statusPublished - 2012

Fingerprint

Hyperinsulinism
Insulin Resistance
Mortality
Neoplasms
Smoking
Blood Pressure
Abdominal Obesity
Fibrinogen
Type 2 Diabetes Mellitus
Italy
Habits
Registries
Diabetes Mellitus
Obesity
Cross-Sectional Studies
Observation
Insulin
Health
Serum
Population

Keywords

  • Cancer
  • Diabetes mellitus
  • Hyperglycemia
  • Hyperinsulinemia
  • Metabolic syndrome
  • Obesity

ASJC Scopus subject areas

  • Endocrinology
  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Insulin resistance/hyperinsulinemia and cancer mortality : The Cremona study at the 15th year of follow-up. / Perseghin, Gianluca; Calori, Giliola; Lattuada, Guido; Ragogna, Francesca; Dugnani, Erika; Garancini, Maria Paola; Crosignani, Paolo; Villa, Marco; Bosi, Emanuele; Ruotolo, Giacomo; Piemonti, Lorenzo.

In: Acta Diabetologica, Vol. 49, No. 6, 2012, p. 421-428.

Research output: Contribution to journalArticle

Perseghin, Gianluca ; Calori, Giliola ; Lattuada, Guido ; Ragogna, Francesca ; Dugnani, Erika ; Garancini, Maria Paola ; Crosignani, Paolo ; Villa, Marco ; Bosi, Emanuele ; Ruotolo, Giacomo ; Piemonti, Lorenzo. / Insulin resistance/hyperinsulinemia and cancer mortality : The Cremona study at the 15th year of follow-up. In: Acta Diabetologica. 2012 ; Vol. 49, No. 6. pp. 421-428.
@article{4952d1e03b98436ebd8a204807444fe6,
title = "Insulin resistance/hyperinsulinemia and cancer mortality: The Cremona study at the 15th year of follow-up",
abstract = "Type 2 diabetes is associated with risk of cancer. Hyperinsulinemia and insulin resistance may be the link with cancer, but whether this is independent of the diabetes status, obesity/visceral obesity and metabolic syndrome is uncertain and the present study wanted to address this issue. Fifteen-year all-cause, CVD and cancer mortality data were obtained through the Regional Health Registry in 2,011 out of 2,074 Caucasian middle-aged individuals of the Cremona Study, a population study on the prevalence of diabetes mellitus in Italy in which anthropometric and metabolic characteristics were collected. During the 15-year observation period, 495 deaths were registered: 221 CVD related and 180 cancer related. Age and sex were independently associated with all-cause, cancer and CVD mortality rates. Age- and sex-adjusted analysis showed that HOMA-IR, cigarette smoking and diabetes were independently associated with all-cause mortality; HOMA-IR, systolic blood pressure and fibrinogen were independently associated with CVD mortality; HOMA-IR and smoking habit were independently associated with cancer mortality. Individuals in the highest quintile of serum insulin had a 62{\%} higher risk of cancer mortality (HR = 1.62 95{\%} CI: 1.19-2.20; P",
keywords = "Cancer, Diabetes mellitus, Hyperglycemia, Hyperinsulinemia, Metabolic syndrome, Obesity",
author = "Gianluca Perseghin and Giliola Calori and Guido Lattuada and Francesca Ragogna and Erika Dugnani and Garancini, {Maria Paola} and Paolo Crosignani and Marco Villa and Emanuele Bosi and Giacomo Ruotolo and Lorenzo Piemonti",
year = "2012",
doi = "10.1007/s00592-011-0361-2",
language = "English",
volume = "49",
pages = "421--428",
journal = "Acta Diabetologica",
issn = "0940-5429",
publisher = "Springer-Verlag Italia s.r.l.",
number = "6",

}

TY - JOUR

T1 - Insulin resistance/hyperinsulinemia and cancer mortality

T2 - The Cremona study at the 15th year of follow-up

AU - Perseghin, Gianluca

AU - Calori, Giliola

AU - Lattuada, Guido

AU - Ragogna, Francesca

AU - Dugnani, Erika

AU - Garancini, Maria Paola

AU - Crosignani, Paolo

AU - Villa, Marco

AU - Bosi, Emanuele

AU - Ruotolo, Giacomo

AU - Piemonti, Lorenzo

PY - 2012

Y1 - 2012

N2 - Type 2 diabetes is associated with risk of cancer. Hyperinsulinemia and insulin resistance may be the link with cancer, but whether this is independent of the diabetes status, obesity/visceral obesity and metabolic syndrome is uncertain and the present study wanted to address this issue. Fifteen-year all-cause, CVD and cancer mortality data were obtained through the Regional Health Registry in 2,011 out of 2,074 Caucasian middle-aged individuals of the Cremona Study, a population study on the prevalence of diabetes mellitus in Italy in which anthropometric and metabolic characteristics were collected. During the 15-year observation period, 495 deaths were registered: 221 CVD related and 180 cancer related. Age and sex were independently associated with all-cause, cancer and CVD mortality rates. Age- and sex-adjusted analysis showed that HOMA-IR, cigarette smoking and diabetes were independently associated with all-cause mortality; HOMA-IR, systolic blood pressure and fibrinogen were independently associated with CVD mortality; HOMA-IR and smoking habit were independently associated with cancer mortality. Individuals in the highest quintile of serum insulin had a 62% higher risk of cancer mortality (HR = 1.62 95% CI: 1.19-2.20; P

AB - Type 2 diabetes is associated with risk of cancer. Hyperinsulinemia and insulin resistance may be the link with cancer, but whether this is independent of the diabetes status, obesity/visceral obesity and metabolic syndrome is uncertain and the present study wanted to address this issue. Fifteen-year all-cause, CVD and cancer mortality data were obtained through the Regional Health Registry in 2,011 out of 2,074 Caucasian middle-aged individuals of the Cremona Study, a population study on the prevalence of diabetes mellitus in Italy in which anthropometric and metabolic characteristics were collected. During the 15-year observation period, 495 deaths were registered: 221 CVD related and 180 cancer related. Age and sex were independently associated with all-cause, cancer and CVD mortality rates. Age- and sex-adjusted analysis showed that HOMA-IR, cigarette smoking and diabetes were independently associated with all-cause mortality; HOMA-IR, systolic blood pressure and fibrinogen were independently associated with CVD mortality; HOMA-IR and smoking habit were independently associated with cancer mortality. Individuals in the highest quintile of serum insulin had a 62% higher risk of cancer mortality (HR = 1.62 95% CI: 1.19-2.20; P

KW - Cancer

KW - Diabetes mellitus

KW - Hyperglycemia

KW - Hyperinsulinemia

KW - Metabolic syndrome

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=84873683616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873683616&partnerID=8YFLogxK

U2 - 10.1007/s00592-011-0361-2

DO - 10.1007/s00592-011-0361-2

M3 - Article

C2 - 22215126

AN - SCOPUS:84873683616

VL - 49

SP - 421

EP - 428

JO - Acta Diabetologica

JF - Acta Diabetologica

SN - 0940-5429

IS - 6

ER -